Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Antidepressant Suicidality Needs Interim Risk Management, FDAer Maintains

Aug 30 2004

• By The Pink Sheet

Related Content

FDA Action On Antidepressants Questioned; Congress Widens Investigation

Mar 29 2004

FDA Requests Antidepressant Labeling Add Suicidality Warning

Mar 29 2004

GSK Settles On Paxil Data Disclosure, Will Post Past Study Results By 2006

Aug 30 2004

Antidepressant Suicide Data To Be Evaluated For FDA By Columbia University

Jan 26 2004

Antidepressant Suicide Risk In Eight Drug Labels; Pfizer Is Hold-Out

Jun 28 2004

Antidepressant Labeling Should Reflect Negative Pediatric Studies

Feb 09 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window